Sight Sciences, Inc. SGHT
8.93
0.25
2.88%
as of 25 Sep
- Market cap
- $478.2M
- P/E
- 0.0×
Follow SGHT
Insider Buys
alert about insiders buying in the last 12 month
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 8.29 | 8.29 | 8.29 | 9.59 | 8.26 | 3.06 | 2.28 | 5.35 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (25.89) | (25.89) | (25.89) | (43.81) | (38.03) | (38.25) | (52.76) | (226.35) |
P/B ratio |
— | 0.00 | 0.00 | 0.00 | 2.02 | 3.68 | 2.06 | 2.09 | 6.47 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 2.02 | 3.68 | 2.06 | 2.09 | 6.47 |
EV/Sales |
— | 8.21 | 8.21 | 8.21 | 4.95 | 6.15 | 1.77 | 1.30 | 4.71 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (7.51) | (7.51) | (7.51) | (4.61) | (5.78) | (3.05) | (4.64) | (12.26) |
EV/FCF |
— | (7.37) | (7.37) | (7.37) | (4.54) | (5.70) | (3.00) | (4.56) | (12.11) |
Quick Ratio |
— | 2.09 | 3.45 | 7.18 | 19.95 | 11.23 | 12.44 | 8.48 | 9.22 |
Current Ratio |
— | 2.47 | 3.82 | 7.58 | 20.52 | 11.77 | 13.29 | 9.04 | 10.22 |
Net Debt/EBITDA |
— | (2.10) | (2.41) | 0.94 | 4.54 | 1.82 | 1.86 | 1.65 | 1.45 |
Debt/Assets |
0.00% | 421.95% | 254.37% | 44.43% | 11.84% | 16.12% | 20.36% | 27.55% | 34.95% |
Debt/Equity |
— | (1.18) | (1.43) | (0.36) | 0.14 | 0.21 | 0.28 | 0.45 | 0.63 |
Asset Turnover |
— | 1.86 | 1.20 | 0.53 | 0.28 | 0.29 | 0.43 | 0.52 | 0.60 |
Operating CF/Net income |
— | 1.01 | 0.97 | 0.93 | 0.83 | 0.88 | 0.85 | 0.43 | 0.77 |
Capex/Depreciation |
— | 0.00 | 0.00 | (0.84) | (0.61) | (0.71) | (0.64) | (0.26) | (0.16) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 34.17% | 61.85% | 48.34% | (87.90%) | (43.98%) | (39.64%) | (49.59%) | (50.74%) | |
| — | (353.10%) | (133.23%) | (67.01%) | (35.67%) | (34.97%) | (29.26%) | (33.29%) | (29.77%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | (701.56%) | (556.90%) | (223.54%) | (484.25%) | (188.86%) |
Return on Tangible Assets |
— | (278.23%) | (111.33%) | (55.43%) | (23.76%) | (44.59%) | (36.48%) | (40.92%) | (37.19%) |
Average Days of Receivables |
— | 87.98 | 64.00 | 70.82 | 64.93 | 77.51 | 64.34 | 49.29 | 45.98 |
Research and Development Expense of Revenue |
— | 72.06% | 34.80% | 32.11% | 31.93% | 32.05% | 21.66% | 22.53% | 18.88% |
Selling, General and Administrative Expense of Revenue |
— | 186.76% | 140.14% | 151.03% | 155.63% | 168.32% | 134.34% | 126.24% | 115.25% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 1.80% | 10.38% | 18.17% | 17.99% | 21.38% | 16.87% |
Graham Net Nets |
— | (0.38) | (0.38) | (0.38) | 0.49 | 0.27 | 0.47 | 0.46 | 0.15 |
Graham Number |
— | 0.00 | 0.00 | 9.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (12.41%) | (12.41%) | (12.41%) | (22.12%) | (14.61%) | (22.35%) | (28.30%) | (9.46%) |
Free Cash Flow Yield |
— | (13.44%) | (13.44%) | (13.44%) | (11.36%) | (13.05%) | (19.34%) | (12.46%) | (7.27%) |
Revenue per Share |
— | 0.16 | 0.50 | 2.95 | 1.83 | 1.49 | 1.67 | 1.59 | 1.48 |
Operating CF per Share |
— | (0.31) | (0.53) | (3.44) | (1.97) | (1.59) | (0.97) | (0.45) | (0.57) |
Capex per Share |
— | 0.00 | 0.00 | (0.10) | (0.03) | (0.02) | (0.02) | (0.01) | 0.00 |
Free Cash Flow per Share |
— | (0.31) | (0.53) | (3.54) | (2.00) | (1.61) | (0.99) | (0.45) | (0.57) |
Cash per Share |
— | 0.09 | 0.45 | 6.57 | 9.75 | 3.87 | 2.84 | 2.40 | 1.76 |
Shareholders Equity per Share |
— | (0.62) | (1.17) | (9.50) | 8.68 | 3.35 | 2.47 | 1.75 | 1.23 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (0.62) | (1.17) | (9.50) | 8.68 | 3.35 | 2.47 | 1.75 | 1.23 |
Free Cash Flow |
— | (14.47) | (25.00) | (33.13) | (53.35) | (76.93) | (47.97) | (22.74) | (29.92) |
Working Capital |
— | 4.27 | 20.67 | 61.32 | 263.53 | 191.86 | 150.62 | 124.31 | 101.71 |
Capital Expenditures |
— | (0.57) | (0.67) | (0.95) | (0.81) | (0.97) | (0.79) | (0.38) | (0.22) |
Net Current Asset Value |
— | (29.89) | (57.42) | (91.02) | 228.96 | 156.68 | 116.44 | 84.46 | 61.38 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 0.00 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 |
Net Profit Margin |
— | (189.77%) | (110.80%) | (125.52%) | (128.61%) | (120.90%) | (68.53%) | (64.49%) | (49.67%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.07 | 0.17 | 0.89 | 0.92 | 0.87 | 0.75 | 0.93 | 0.89 |
Cash ROIC |
— | (162.65%) | (61.61%) | (667.26%) | (10.27%) | (20.44%) | (16.71%) | (9.68%) | (15.95%) |
Accounts Receivable Turnover |
— | 2.55 | 7.90 | 5.85 | 6.96 | 5.98 | 5.51 | 6.37 | 7.54 |
Accounts Payable Turnover |
— | 1.11 | 3.12 | 4.12 | 3.13 | 4.09 | 5.38 | 6.77 | 7.05 |
Inventory Turnover |
— | 1.71 | 4.79 | 3.80 | 2.84 | 2.58 | 1.70 | 1.63 | 1.52 |
Average Days of Payables |
— | 293.34 | 129.12 | 85.53 | 142.06 | 79.37 | 53.18 | 53.30 | 45.83 |
Days of Inventory on Hand |
— | 75.87 | 125.16 | 102.97 | 147.31 | 180.54 | 241.13 | 199.35 | 265.02 |
Average Receivables |
— | 2.95 | 2.95 | 4.73 | 7.04 | 11.93 | 14.72 | 12.54 | 10.27 |
Average Payables |
— | 2.10 | 2.10 | 2.24 | 2.75 | 3.02 | 2.21 | 1.71 | 1.52 |
Average Inventory |
— | 1.37 | 1.37 | 2.42 | 3.04 | 4.79 | 6.98 | 7.09 | 7.05 |
Average Assets |
— | 4.05 | 19.42 | 51.77 | 176.50 | 246.63 | 189.86 | 154.75 | 129.07 |
Average Common Equity |
— | (41.82) | (41.82) | (71.77) | 71.63 | 196.09 | 140.15 | 103.87 | 75.73 |
Columns are period end dates